DIR Fee Relief Leads NACDS RxIMPACT Pharmacy Tours
Members of Congress were able to grasp firsthand critical pharmacy public policy issues when they toured pharmacies in their home states and congressional districts.
Members of Congress were able to grasp firsthand critical pharmacy public policy issues when they toured pharmacies in their home states and congressional districts.
NACDS President & CEO Steven C. Anderson, IOM, CAE, issued a statement regarding pharmacies' long-standing and ongoing commitment as part of the opioid-abuse solution.
NACDS: “Dire” problem for patients, pharmacies must be fixed in drug-pricing bill
Sixty-two percent of Missouri voters support e-prescribing requirement as a fraud and abuse prevention strategy.
During the Fourth of July congressional recess, members of Congress learned firsthand about key pharmacy issues—particularly about the need for direct and indirect remuneration (DIR) fee relief as part of a drug-pricing legislative package.
Sixty-four percent of Delaware voters support e-prescribing requirement as a fraud and abuse prevention strategy.
NACDS thanks addiction, pain management experts for urging legislation that addresses epidemic while remaining sensitive to chronic pain sufferers.
Sixty-two percent of Kansas voters support e-prescribing requirement as a fraud and abuse prevention strategy.
Pharmacy groups unite to laud bipartisan Congressional focus on closing the loophole that inflates drug costs for patients and Medicare, and jeopardizes pharmacies.
6-in-10 Texas voters back key provisions of bill, which is sensitive to those suffering from chronic pain.